Report Summary
Eternity Insights has published a new study on Global RNAi For Therapeutic Market focusing on key segments as by Type (siRNA,miRNA,shRNA, Other), by Application (Cancer,Cardiovascular,HBV,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global RNAi For Therapeutic Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
RNAi For Therapeutic Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global RNAi For Therapeutic Market Size, 2018-2028 (USD Million)
To learn more about this report
Global RNAi For Therapeutic Market Segmentation:
RNAi For Therapeutic Market, By Type
RNAi For Therapeutic Market, By Application
- Cancer
- Cardiovascular
- HBV
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global RNAi For Therapeutic market in terms of demand generation. The RNAi For Therapeutic market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for RNAi For Therapeutic market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global RNAi For Therapeutic Market Taxonomy:
To learn more about this report
Global RNAi For Therapeutic Market Competitive Landscape
The global RNAi For Therapeutic market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Alnylam Pharmaceuticals
- Arbutus Biopharma (Tekmira)
- Arrowhead
- Dicerna Pharmaceuticals
- Mirna Therapeutics
- Quark Pharmaceuticals
- RXi Pharmaceuticals
- Silence Therapeutics
- Benitec Biopharma
- miRagen Therapeutics
- Sylentis
- Gradalis
- Sirnaomics
- Silenseed
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
siRNA,miRNA,shRNA, Other |
| By Application Outlook |
Cancer,Cardiovascular,HBV,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Alnylam Pharmaceuticals,Arbutus Biopharma (Tekmira),Arrowhead,Dicerna Pharmaceuticals,Mirna Therapeutics,Quark Pharmaceuticals,RXi Pharmaceuticals,Silence Therapeutics,Benitec Biopharma,miRagen Therapeutics,Sylentis,Gradalis,Sirnaomics,Silenseed |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Chapter 1 RNAi for Therapeutic Market Overview
1.1 RNAi for Therapeutic Definition
1.2 Global RNAi for Therapeutic Market Size Status and Outlook (2014-2026)
1.3 Global RNAi for Therapeutic Market Size Comparison by Region (2014-2026)
1.4 Global RNAi for Therapeutic Market Size Comparison by Type (2014-2026)
1.5 Global RNAi for Therapeutic Market Size Comparison by Application (2014-2026)
1.6 Global RNAi for Therapeutic Market Size Comparison by Sales Channel (2014-2026)
1.7 RNAi for Therapeutic Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 RNAi for Therapeutic Market Segment Analysis by Player
2.1 Global RNAi for Therapeutic Sales and Market Share by Player (2017-2018)
2.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2017-2018)
2.3 Global RNAi for Therapeutic Average Price by Player (2017-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 RNAi for Therapeutic Market Segment Analysis by Type
3.1 Global RNAi for Therapeutic Market by Type
3.1.1 siRNA
3.1.2 miRNA
3.1.3 shRNA
3.2 Global RNAi for Therapeutic Sales and Market Share by Type (2014-2018)
3.3 Global RNAi for Therapeutic Revenue and Market Share by Type (2014-2018)
3.4 Global RNAi for Therapeutic Average Price by Type (2014-2018)
3.5 Leading Players of RNAi for Therapeutic by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 RNAi for Therapeutic Market Segment Analysis by Application
4.1 Global RNAi for Therapeutic Market by Application
4.1.1 Cancer
4.1.2 Cardiovascular
4.1.3 HBV
4.1.4 Other
4.2 Global RNAi for Therapeutic Sales and Market Share by Application (2014-2018)
4.3 Leading Consumers of RNAi for Therapeutic by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 RNAi for Therapeutic Market Segment Analysis by Sales Channel
5.1 Global RNAi for Therapeutic Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global RNAi for Therapeutic Sales and Market Share by Sales Channel (2014-2018)
5.3 Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 RNAi for Therapeutic Market Segment Analysis by Region
6.1 Global RNAi for Therapeutic Market Size and CAGR by Region (2014-2026)
6.2 Global RNAi for Therapeutic Sales and Market Share by Region (2014-2018)
6.3 Global RNAi for Therapeutic Revenue and Market Share by Region (2014-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America RNAi for Therapeutic Market Share by Type
6.4.3 North America RNAi for Therapeutic Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe RNAi for Therapeutic Market Share by Type
6.5.3 Europe RNAi for Therapeutic Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific RNAi for Therapeutic Market Share by Type
6.6.3 Asia-Pacific RNAi for Therapeutic Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America RNAi for Therapeutic Market Share by Type
6.7.3 South America RNAi for Therapeutic Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa RNAi for Therapeutic Market Share by Type
6.8.3 Middle East & Africa RNAi for Therapeutic Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading RNAi for Therapeutic Players
7.1 Alnylam Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Arbutus Biopharma (Tekmira)
7.3 Arrowhead
7.4 Dicerna Pharmaceuticals
7.5 Mirna Therapeutics
7.6 Quark Pharmaceuticals
7.7 RXi Pharmaceuticals
7.8 Silence Therapeutics
7.9 Benitec Biopharma
7.10 miRagen Therapeutics
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed
Chapter 8 Upstream and Downstream Analysis of RNAi for Therapeutic
8.1 Industrial Chain of RNAi for Therapeutic
8.2 Upstream of RNAi for Therapeutic
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of RNAi for Therapeutic
8.3.1 Leading Distributors/Dealers of RNAi for Therapeutic
8.3.2 Leading Consumers of RNAi for Therapeutic
Chapter 9 Development Trend of RNAi for Therapeutic (2019-2026)
9.1 Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2019-2026)
9.2 Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2019-2026)
9.3 Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2019-2026)
9.4 Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2019-2026)
9.5 Global RNAi for Therapeutic Market Size Forecast by Sales Channel (2019-2026)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
